Effect of Externally Implantable Tissue Expansion Device on Scar Length

Northwestern University

Overview

The purpose of this study is to assess whether brief use of an externally implantable tissue expansion device following excisional skin cancer surgery will significantly reduce the diameter of the final wound defect, and hence the length of the final linear primary closure. The secondary objective is to assess the functional benefits, if any, associated with use of the tissue expander.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

SINGLE

Conditions

Skin Lesion

Interventions

Externally Implantable Tissue Expansion DeviceDEVICE

Will Apply Externally Implantable Tissue Expansion Device for 2 Days

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria * Subjects ages 18-80 years old * Subjects who are undergoing an excision of a large cutaneous lesion * Subjects with an immediate post-excision wound defect at least 2.5 cm in diameter * Subjects undergoing surgery on the trunk or extremities * The subject has willingness and the ability to understand and provide informed consent for the use of their tissue and communicate with the investigator. * Subjects who are willing to undergo no other treatments for the scars for the duration of the study. Exclusion Criteria * Subjects with scalp wounds * Subjects who are unable to understand the protocol or give informed consent

Locations (1)

Northwestern University Dermatology

Chicago, Illinois, United States

Outcomes

Primary Outcomes

Surface area (in cm2) of subject's scar

Time frame: 3 months

Secondary Outcomes

Treating physicians will note any adverse effects

Time frame: 3 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.